Role of nanotechnology and gene delivery systems in TRAIL-based therapies

Since its identification as a member of the tumour necrosis factor (TNF) family, TRAIL (TNF-related apoptosis-inducing ligand) has emerged as a new avenue in apoptosis-inducing cancer therapies. Its ability to circumvent the chemoresistance of conventional therapeutics and to interact with cancer st...

Descripción completa

Detalles Bibliográficos
Autores principales: Naoum, George E, Tawadros, Fady, Farooqi, Ammad Ahmad, Qureshi, Muhammad Zahid, Tabassum, Sobia, Buchsbaum, Donald J, Arafat, Waleed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990059/
https://www.ncbi.nlm.nih.gov/pubmed/27594905
http://dx.doi.org/10.3332/ecancer.2016.660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990059/
https://www.ncbi.nlm.nih.gov/pubmed/27594905
http://dx.doi.org/10.3332/ecancer.2016.660

Ejemplares similares